stella
beta
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study — Stella
Home
/
Breast Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to Breast Cancer trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania